first
quarter
cochran
collabor
independ
nonprofit
nongovernment
organ
report
tamiflu
gener
name
oseltamivir
work
effect
furthermor
caus
side
effect
includ
vomit
nausea
headach
renal
problem
psychiatr
event
risk
seriou
complic
pneumonia
use
treatment
prophylaxi
influenza
addit
may
induc
seriou
heart
rhythm
problem
drug
regul
claim
medicin
given
million
peopl
swine
flu
pandem
howev
roch
swiss
drug
manufactur
disagre
overal
conclus
await
decis
intern
center
health
organ
recent
articl
publish
lancet
respiratori
medicin
websit
larg
group
pride
consortium
investig
fund
f
hoffmannla
roch
effect
tamiflu
reveal
studi
regardless
aforement
side
effect
import
neuraminidas
inhibitor
treatment
influenza
reduct
mortal
rate
due
influenza
discuss
eventu
conclud
oral
tamiflu
oseltamivir
might
reduc
mortal
compar
treatment
regardless
medicin
still
prescrib
tablet
patient
worldwid
stock
purchas
batch
pass
expiri
date
worth
note
government
depart
nation
health
servic
nh
british
govern
spent
million
sterl
pound
stockpil
medicin
case
flu
outcri
therefor
riski
consid
better
noth
anoth
viral
pandem
suddenli
becom
epidem
case
corona
viru
howev
moral
correct
solut
import
issu
consequ
answer
question
titl
bring
solut
insist
urgenc
find
replac
safe
effici
treat
influenza
number
one
global
killer
especi
children
elderli
flu
nasti
diseas
new
one
aris
everi
year
avian
flu
virus
outbreak
aros
long
swine
flu
virus
recent
earli
corona
viru
outbreak
ensu
alreadi
taken
mani
live
middl
east
especi
saudi
arabia
hajj
pilgrimag
million
peopl
worship
huge
intern
close
gather
recent
public
discuss
solut
viral
infect
idea
combin
synthet
medicin
call
arbidol
natur
product
call
new
medicin
increas
individu
potenc
singl
dose
formul
paper
introduc
power
natur
medicin
effect
infecti
diseas
aid
due
interferon
action
gener
lymphocyt
consequ
increas
cell
count
therebi
improv
life
expect
qualiti
life
afflict
patient
would
combin
arbidol
synthet
medicin
good
efficaci
signific
side
effect
discuss
sever
studi
use
within
last
decad
latter
also
two
decad
pharmacokinet
safeti
efficaci
subject
mani
public
implement
sever
human
clinic
trial
influenza
treatment
arbidol
toxic
low
anim
human
studi
therefor
medicin
consid
safe
human
use
follow
year
prescript
major
issu
risen
far
comparison
mechanist
tamiflu
relenza
gener
name
zanamivir
consid
neuraminidas
inhibitor
tamiflu
administ
oral
tablet
latter
administ
inhal
mechan
action
medicin
similar
bring
effect
react
enzym
exist
surfac
influenza
viru
comparison
arbidolimod
combin
differ
mechan
action
addit
arbidol
abil
react
viru
protein
disabl
viru
prevent
penetr
cell
combin
also
distribut
bodi
quickli
interferon
induc
well
possess
antioxid
activ
essenti
element
selenium
boost
immun
system
therefor
patient
immun
system
prevent
bodi
becom
ill
prophylaxi
influenza
also
fight
viral
diseas
bodi
need
howev
influenc
treatment
influenza
discuss
specif
anywher
literatur
biolog
aspect
flavonoid
gener
subject
mani
relev
studi
major
class
phytochem
includ
quercetin
rutin
apigenin
catechin
etc
report
possess
antivir
activ
type
virus
top
caus
gener
lymphocyt
consequ
increas
cell
count
therebi
improv
life
expect
qualiti
life
viral
afflict
patient
show
influenc
prepar
addit
differ
studi
shown
increas
interferon
releas
host
cell
significantli
thu
regul
level
consequ
increas
cell
count
one
interferon
interferon
gamma
crucial
innat
adapt
immun
also
case
arbidol
also
show
interferonogen
activ
therefor
efficaci
influenza
directli
subject
articl
increas
level
show
fight
infecti
diseas
result
provid
strong
evid
indic
increas
efficaci
arbidol
treatment
patient
consequ
new
propos
idea
expect
produc
novel
medicin
increas
cell
number
boost
immun
system
thu
better
choic
prevent
cure
viral
infecti
diseas
gener
must
emphas
chemic
arbidol
bromoindol
compound
gener
indol
especi
bromosubstitut
one
consid
good
sourc
infecti
virus
hiv
hepat
b
c
toxicolog
studi
novel
medicin
carri
mice
investig
show
practic
zero
toxic
dose
rang
gkg
gkg
unpublish
data
cours
batteri
genotox
pharmacokinet
studi
includ
drug
interact
test
relat
test
immunosuppress
patient
explor
deepli
novel
medicin
studi
author
believ
new
hypothes
idea
combin
arbidol
stronger
agent
new
formul
discuss
bring
safe
effect
medicin
prevent
cure
infecti
diseas
differ
type
influenza
plan
clinic
trial
pharmacokinet
studi
prove
promis
